Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MYGN

Myriad Genetics Inc

May 01 • 04:00PM ET

4.80

+0.05 1.05 %

Healthcare • Diagnostics & Research • USA • Small • NASD

Peers: ILMN GH INCY QGEN EXAS NTLA CRSP CDNA TXG TWST

| Held by: VTI XBI IWM VXF IWN IBB FNDA FESM SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.95	Insider Own	6.83%	Shs Outstand	93.50M	Perf Week	0.42%
Market Cap	448.84M	Forward P/E	36.81	EPS next Y	0.13	Insider Trans	2.32%	Shs Float	87.12M	Perf Month	4.58%
Enterprise Value	509.04M	PEG	0.69	EPS next Q	-0.07	Inst Own	100.88%	Short Float	9.46%	Perf Quarter	-14.59%
Income	-365.90M	P/S	0.54	EPS this Y	-41.95%	Inst Trans	-5.32%	Short Ratio	4.83	Perf Half Y	-39.32%
Sales	824.50M	P/B	1.22	EPS next Y	274.39%	ROA	-42.20%	Short Interest	8.24M	Perf YTD	-21.95%
Book/sh	3.94	P/C	3.00	EPS next 5Y	53.61%	ROE	-68.45%	52W High	8.59 -44.12%	Perf Year	-32.68%
Cash/sh	1.60	P/FCF	-	EPS past 3/5Y	-41.67% -8.03%	ROIC	-64.09%	52W Low	3.76 27.66%	Perf 3Y	-77.88%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	6.72% 5.24%	Gross Margin	67.05%	Volatility	5.46% 6.23%	Perf 5Y	-84.12%
Dividend TTM	-	EV/Sales	0.62	EPS Y/Y TTM	-181.57%	Oper. Margin	-8.22%	ATR (14)	0.29	Perf 10Y	-86.67%
Dividend Ex-Date	-	Quick Ratio	2.26	Sales Y/Y TTM	-1.56%	Profit Margin	-44.38%	RSI (14)	49.59	Recom	3.08
Dividend Gr. 3/5Y	- -	Current Ratio	2.49	EPS Q/Q	81.84%	SMA20	-0.44%	Beta	1.81	Target Price	7.03
Payout	-	Debt/Eq	0.57	Sales Q/Q	-0.38%	SMA50	0.62%	Rel Volume	1.15	Prev Close	4.75
Employees	2700	LT Debt/Eq	0.55	Earnings	May 05 AMC	SMA200	-20.54%	Avg Volume	1.71M	Price	4.80
IPO	Oct 06, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	368.46% 1.14%	Trades		Volume	1,953,168	Change	1.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)